Literature DB >> 19228275

Down syndrome: a cardiovascular perspective.

J C Vis1, M G J Duffels, M M Winter, M E Weijerman, J M Cobben, S A Huisman, B J M Mulder.   

Abstract

This review focuses on the heart and vascular system in patients with Down syndrome. A clear knowledge on the wide spectrum of various abnormalities associated with this syndrome is essential for skillful management of cardiac problems in patients with Down syndrome. Epidemiology of congenital heart defects, cardiovascular aspects and thyroid-related cardiac impairment in patients with Down syndrome will be discussed.

Entities:  

Mesh：

Year:  2009        PMID： 19228275     DOI： 10.1111/j.1365-2788.2009.01158.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN： 0964-2633


  44 in total

1.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

Review 2.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

Review 3.  The changing epidemiology of congenital heart disease.

Authors:  Teun van der Bom; A Carla Zomer; Aeilko H Zwinderman; Folkert J Meijboom; Berto J Bouma; Barbara J M Mulder
Journal:  Nat Rev Cardiol       Date:  2010-11-02       Impact factor: 32.419

4.  Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes.

Authors:  Mireia Vilardell; Axel Rasche; Anja Thormann; Elisabeth Maschke-Dutz; Luis A Pérez-Jurado; Hans Lehrach; Ralf Herwig
Journal:  BMC Genomics       Date:  2011-05-11       Impact factor: 3.969

5.  Comparison of body adiposity index (BAI) and air displacement plethysmograph with estimations of % body fat in adults with Down's syndrome.

Authors:  M Rossato; R A Dellagrana; E de Souza Bezerra; R M da Costa; J O L Dos Santos; D A S Silva; F Diefenthaeler
Journal:  Eur J Clin Nutr       Date:  2017-03-15       Impact factor: 4.016

6.  Down Syndrome - Genetics and Cardiogenetics.

Authors:  Vasilica Plaiasu
Journal:  Maedica (Bucur)       Date:  2017-09

7.  Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease.

Authors:  Alex M Helman; Morgan Siever; Katie L McCarty; Ira T Lott; Eric Doran; Erin L Abner; Frederick A Schmitt; Elizabeth Head
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

8.  Engineered chromosome-based genetic mapping establishes a 3.7 Mb critical genomic region for Down syndrome-associated heart defects in mice.

Authors:  Chunhong Liu; Masae Morishima; Xiaoling Jiang; Tao Yu; Kai Meng; Debjit Ray; Annie Pao; Ping Ye; Michael S Parmacek; Y Eugene Yu
Journal:  Hum Genet       Date:  2013-12-22       Impact factor: 4.132

9.  Opioid use after cardiac surgery in children with Down syndrome.

Authors:  Sara L Van Driest; Anushi Shah; Matthew D Marshall; Hua Xu; Andrew H Smith; Tracy L McGregor; Prince J Kannankeril
Journal:  Pediatr Crit Care Med       Date:  2013-11       Impact factor: 3.624

10.  A functional variant in the cystathionine β-synthase gene promoter significantly reduces congenital heart disease susceptibility in a Han Chinese population.

Authors:  Jian-Yuan Zhao; Xue-Yan Yang; Kai-Hu Shi; Shu-Na Sun; Jia Hou; Zhi-Zhou Ye; Jue Wang; Wen-Yuan Duan; Bin Qiao; Yi-Jiang Chen; Hong-Bing Shen; Guo-Ying Huang; Li Jin; Hong-Yan Wang
Journal:  Cell Res       Date:  2012-09-18       Impact factor: 25.617
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.